Outcomes of the national programme on prevention of mother-to-child transmission of hepatitis B virus in China, 2016–2017
This study investigates the outcomes of the prevention of mother-to-child transmission programme
Abstract
In addition to providing free hepatitis B vaccine (HBvacc) series to all infants in China since 2005, the national programme on prevention of mother-to-child transmission (PMTCT) of hepatitis B virus (HBV) started providing free hepatitis B immunoglobulin for all new-borns born to hepatitis B surface-antigen (HBsAg) positive mothers in 2010. However, few studies have evaluated the effectiveness of the PMTCT programme. Therefore, the authors aimed to investigate the outcomes of the programme and identify associated factors.
This research was supported by the UK Department for International Development’s Operational Research Capacity Building Programme led by the International Union Against TB and Lung Disease (The Union)
Citation
Qiao Y-P, Su M, Song Y, Wang X-Y, Li Z, Li Y-L, Dou L-X, Wang Q, Hann K, Zhang G-M, Huang X-N, Yang Y-N, Jin X, Wang A-L. Outcomes of the national programme on prevention of mother-to-child transmission of hepatitis B virus in China, 2016–2017. Infectious Diseases of Poverty. 2019;8(1):65.